Research ArticleArticle
Open Access
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
Gurjit S. Kaeley, Amy M. Evangelisto, Midori J. Nishio, Sandra L. Goss, Shufang Liu, Jasmina Kalabic and Hartmut Kupper
The Journal of Rheumatology August 2016, 43 (8) 1480-1489; DOI: https://doi.org/10.3899/jrheum.151009
Gurjit S. Kaeley
From the University of Florida College of Medicine, Jacksonville, Florida; Arthritis, Rheumatic and Back Disease Associates, Voorhees, New Jersey; Diablo Clinical Research, Walnut Creek, California; AbbVie Inc., North Chicago, Illinois,
USA; AbbVie Deutschland GmbH and Co. KG., Ludwigshafen,
Germany.
Amy M. Evangelisto
Midori J. Nishio
Sandra L. Goss
Shufang Liu
Jasmina Kalabic
In this issue
The Journal of Rheumatology
Vol. 43, Issue 8
1 Aug 2016
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
Gurjit S. Kaeley, Amy M. Evangelisto, Midori J. Nishio, Sandra L. Goss, Shufang Liu, Jasmina Kalabic, Hartmut Kupper
The Journal of Rheumatology Aug 2016, 43 (8) 1480-1489; DOI: 10.3899/jrheum.151009
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
Gurjit S. Kaeley, Amy M. Evangelisto, Midori J. Nishio, Sandra L. Goss, Shufang Liu, Jasmina Kalabic, Hartmut Kupper
The Journal of Rheumatology Aug 2016, 43 (8) 1480-1489; DOI: 10.3899/jrheum.151009